Humana Inc. (HUM) Stock Analysis

30d

Price: $402.88 · -0.05% · Sector: Healthcare · Industry: Healthcare Plans

Company Overview

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Headquarters: LOUISVILLE, KY · Employees: 67,060 · Website ↗

Financial Health Scores

Health Score
86/100
strong
Profitability
31/100
weak
Valuation Score
75/100
strong
Piotroski F-Score
5/9
Altman Z-Score
2.74
Grey zone
Revenue CAGR
11.78%
Net Income CAGR
-20.22%
FCF Margin
0.93%
Debt Repayment
0.0 yrs
Margin Stability
2.08%

Neutral

Company is effectively debt-free after netting cash.· Current P/E is in the top 3% of historical values.

Analyst Consensus

Hold

Wall Street consensus estimates — not a PMP forecast · Updated Sep 9, 2026

Analyst Recommendations33 analysts · 2026-09-01
8
8
16
Strong Buy 8Buy 8Hold 16Sell 1Strong Sell 0

PMP Score

Coming soon

A point-in-time composite score ranking future winners — built on the same data you see above.

Earnings35%
Awaiting PIT data
Fundamentals30%
Live — see scores above
Momentum25%
Awaiting PIT data
Quality10%
Awaiting PIT data

The earnings pillar requires timestamped analyst-consensus history (point-in-time verified) — currently in vendor procurement. No score is published until the data passes the PIT integrity gate.